• Explore /
  • Poster
  • / The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).

The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).

Abstract Poster

Authors

null

Sara Elena Rebuzzi

Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy

Sara Elena Rebuzzi , Alessio Signori , Sebastiano Buti , Giuseppe Luigi L. Banna , Marco Stellato , Daniele Santini , Umberto Basso , Ugo De Giorgi , Silvia Chiellino , Alessia Salfi , Paolo Andrea Zucali , Cristina Masini , Emanuele Naglieri , Giuseppe Procopio , Michele Milella , Francesco Boccardo , Lucia Fratino , Stefania Pipitone , Camillo Porta , Giuseppe Fornarini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4534)

DOI

10.1200/JCO.2022.40.16_suppl.4534

Abstract #

4534

Poster Bd #

25

Abstract Disclosures

Similar Posters

First Author: Aitzaz Qaisar

First Author: Sara Elena Rebuzzi

First Author: Songzhu Zhao

First Author: Yoshiaki Yamamoto